UTAH MEDICAL PRODUCTS, INC. Long-Term Debt, Maturity, Year Two
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Long-Term Debt, Maturity, Year Two of $4.05 thousand as of 2013-12-31, per its 10-K filed 2014-03-12.
Discontinued › Notes › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2014-03-12
- 2013-12-31: Long-Term Debt, Maturity, Year Two $4.05K.
- 2012-12-31: Long-Term Debt, Maturity, Year Two $4.00K.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2013-12-31 | $4.05K 10-K · filed 2014-03-12 |
| 2012-12-31 | $4.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |